Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Aug 31 2022

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-aug-31-2022

Zydus Lifesciences Limited has informed the Exchange about press release dated 31-Aug-2022 titled Zydus receives two final approvals from the USFDA for Venlafaxine Extended-Release Tablets and Pregabalin Extended-Release Tablets

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases